This study aimed to assess whether combining the TyG index, a surrogate for insulin resistance, with CD4+ T cell count enhanced early prediction of 28-day mortality risk in adults hospitalized with HIV-associated sepsis. The gene discussed is CD4; the disease is Sepsis.